Smital Shah

Insider Reports History

Entity
Individual
Location
C/O Pliant Therapeutics, Inc., 260 Littlefield Avenue, South San Francisco, CA
Signature
/s/ Mike Ouimette, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Smital Shah:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PLIANT THERAPEUTICS, INC. Director Common Stock (Right to Buy) 26.8K $55.7K $2.08 Jun 13, 2024 Direct
Graphite Bio, Inc. Director Stock Option (right to buy) 20K Jul 19, 2023 Direct

Insider Reports Filed by Smital Shah

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PLRX PLIANT THERAPEUTICS, INC. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
GRPH Graphite Bio, Inc. Jul 19, 2023 1 $0 4 Jul 21, 2023 Director
PLRX PLIANT THERAPEUTICS, INC. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
GRPH Graphite Bio, Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 Director
PLRX PLIANT THERAPEUTICS, INC. Jun 16, 2022 1 $0 4 Jun 21, 2022 Director
PLRX PLIANT THERAPEUTICS, INC. Jun 29, 2021 1 $0 4 Jun 30, 2021 Director
GRPH Graphite Bio, Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 Director
GRPH Graphite Bio, Inc. Apr 15, 2021 2 $100K 4 Jul 1, 2021 Director